Personalis, Inc. (PSNL) research
Personalis, Inc.- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Last price
- $16.28
- As of
Personalis, Inc. (PSNL): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-20.
As of . Source: SEC EDGAR filings for PSNL. Method and limitations.
Share the PSNL intelligence card
See the full PSNL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PSNL on one page. Preview it with sample data, then open it live with a free account.
Preview the PSNL dossierActive signals for PSNL
- highCONSENSUS_BUY
3 tracked funds increased PSNL this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +201% to PSNL (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +663% to PSNL (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +213% to PSNL (2026Q2)
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 13.2%, EPS $-0.30 vs $-0.2651 estimate
FREE, NO ACCOUNT
Every signal on PSNL, as it fires
You are seeing 5 of 13 signals recorded on PSNL since 2026-05-27.
The five above landed across 3 days. The other 8 were recorded on 3 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in PSNL (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 71535D106 · 2026Q2 | $6M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 71535D106 · 2026Q2 | $1.9M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 71535D106 · 2026Q2 | $767K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PSNL
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
PSNL against its peers
PSNL's operating margin of -126.4% ranks in the 18th percentile of 18 Diagnostics & Research sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | PSNL | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 69.6M USD | 88.5M USD | 43 | 19 |
| Gross margin | n/a | 62.3% | n/a | 13 |
| Operating margin | -126.4% | -17.6% | 18 | 18 |
| Net margin | -116.7% | -20.6% | 23 | 19 |
| Return on equity | -31.1% | -8.7% | 26 | 16 |
Peers (21): OPK, NEO, CDNA, BLLN, QGEN, BDSX, TWST, ICLR, BNR, FONR, QUCY, IMDX, MBAI, MDXH, PRPO, IDXG, LDDD, AWHL, NDRA, XWEL, ISPC. Left out: ANPCF (no annual filing), PMDI (period gap), ADVB (no annual filing), BIAF (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PSNL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more PSNL signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PSNLand get the insider, 13F, options, and confluence read in one view.